Do No Harm Blog Post: Adult Taking Charge

Date: 08/04/2014

Latest entry from Do No Harm‘s blog: Stem Cells that Work

The California Institute for Regenerative Medicine’s (CIRM) choice for its new head would have been unthinkable when the institute was first established almost 10 years ago.   Yet today, it seems fitting, given the direction stem cell research has taken over the same decade.

C. Randal Mills recently took over as CIRM’s new president.  Before taking his new post, Mills had been president and CEO of Osiris Therapeutics.  Osiris pursues therapies based on stem cell research, so in that regard, Mill’s appointment to head up CIRM would seem highly appropriate.

However, Osiris pursues non-embryonic, adult stem cell research, particularly with mesenchymal stem cells.  That why his appointment would have been so unthinkable at CIRM’s founding. (more . . .)